Knockdown of ADAMDEC1 inhibits the progression of glioma in vitro.

CONCLUSION: Downregulation of ADAMDEC1 could significantly inhibit the tumorigenesis of glioma in vitro, which may serve as a novel target for the treatment of glioma. PMID: 32378728 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32378728?dopt=Abstract

Source: Histology and Histopathology - May 8, 2020 Category: Cytology Tags: Histol Histopathol Source Type: research